Skip to content

Treatment of Periodontal bony defect using various bone graft

Comparison of Injectable Biocomposites AND Hydroxyapatite Bone Cement in the Treatment Of Periodontal Intrabony Defects - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057332
Enrollment
30
Registered
2023-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: BIOCOMPOSITES: The biocomposites are blends of beta tricalcium phosphate compounds (beta TCP) and calcium sulphate (CS). The Injectable biocomposites is specifically formulated to provi

Sponsors

Sardar Patel Post Graduate of Dental and Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient age between16-40 years diagnosed with periodontitis 2.Teeth selection All the teeth diagnosed with periodontal osseous intrabony defect Two or three wall defect on clinical and radiographic evaluation 3.PD more than or equal to 4 mm and an intrabony component more than or equal to 3 mm 4.The depth of the intraosseous component of the defect was evaluated clinically and radiographically during the screening phase but it had to be confirmed during surgery 5.Systemically healthy patients 6.Patients with established willingness and ability to perform adequate oral hygiene

Exclusion criteria

Exclusion criteria: 1. Heavy smoking (more than 10 cigarettes) 2. Presence of underlying medical conditions such as immunosuppression or diabetes pregnancy and medically compromised conditions that would put the patient at risk for periodontal surgery

Design outcomes

Primary

MeasureTime frame
The outcome expected will be to compare the regenerative capacity of injectable biocomposites & granular form of Hydroxyapatites in an adjunct with OFD in treatment of intrabony defects.Timepoint: Baseline 3 months 6 months

Secondary

MeasureTime frame
the secondary outcome is radiographic evaluation of the bone fill & bone density post operative in treatments of intrabony defects.Timepoint: 6 months post operative

Countries

India

Contacts

Public ContactHimani Tripathi

Sardar Patel Post Graduate Institute of Dental and Medical Sciences

ajita.meenawat@gmail.com9307847070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026